Uptick Newswire Hosts PCT Health (a division of PCTL) on the Stock Day Podcast to Discuss The Company’s Innovative Technology and Recent Representative Agreement with DTS

World News: . []

PHOENIX, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Uptick Newswire Stock Day Podcast welcomed PCT LTD (OTC Pink: PCTL), a business focused on acquiring, developing, and providing sustainable, environmentally safe disinfecting and tracking technologies products. CEO, Jody Read, joined Stock Day host Everett Jolly to discuss the Company’s innovative products, as well as their recent Manufacturer’s Representative Agreement with DTS.

To begin the interview, Jolly asked Read to share with listeners what the Company focuses on. Read explained that Company specializes in developing safe, non-harmful, surface disinfecting and cleaning products that are strong enough to address Hospital Associated Infections (HAI’s) as well as advanced technology to drive facility efficiency and improve outcomes. Recently, the Company shifted their focus to a new set of target markets, which has already proven to provide substantial traction and growth.

Jolly then asked about the Company’s recent press release regarding a Manufacturer’s Representative Agreement with DTS in Cleveland, Ohio. Read explained that the Company has implemented an aggressive representative program and is excited to welcome DTS onboard, as well as utilize the existing market that DTS has to offer.

Jolly then inquired about Read’s move from COO to CEO and asked where he see the Company headed in the future. Read explained that the Company over the past two years has analyzed what markets to implement its products that will drive growth faster and provide the most opportunity for profitability.  PCT is focusing on the healthcare and agriculture markets due to significant and immediate needs where PCT’s products can have a major impact and PCT has pinpointed exactly what consumers are looking for in terms of technology and available solutions.

Read also shared that the Company has developed an entirely new system for disinfecting hospital surfaces that provides for facility-wide disinfection that implements RFID, SMART Devices, Patented bottle and protocol tracking, along with a suite of electrostatic applicators to drive efficiency and efficacy. All of this is packaged as an all-inclusive system that is paid for via a monthly fee. “This eliminates the long-term capital budget process and makes it easier for us to implement the systems quickly.”

Jolly asked what makes the Company stand out from others in its class. Read explained that there are numerous factors that differentiate the Company from others, including the fact that their disinfectant is entirely EPA registered and is one of the few systems on the market that kills C.Diff with a proven six-log reduction, . The technology offered by the Company is also incredibly advanced compared to other competitors in its space and allows customers a much more efficient and innovative way to disinfect their required surfaces.

Read also shared that their products are developed with natural ingredients that are safe for the staff, patients, and furniture. Currently, many hospitals are forced to regularly replace their furniture due to the harshness of the chemicals in their cleaning products, making the products available at PCT even more revolutionary.

Read closed by sharing that the products and systems developed at PCT are receiving an incredible amount of positive feedback and are unlike anything available on the market.  Every Hospital that has trialed the system has signed long-term agreements.

To hear the entire interview with , listen to the podcast here:

PCT Corp’s business mission is to profitably provide state-of-the-art Electro-Chemical Activation equipment, disinfecting fluid solutions and PCT Corp's patented tracking system to hospitals and other facilities for the documentable remediation of Hospital Acquired Infections (HAI's) from organisms such as Clostridium difficile (C. diff.), MRSA, VRE, CRE, Klebsiella pneumoniae, and Pseudomonas, as well as to sell ECA fluid solutions to agricultural markets for the remediation, control and suppression of microbial contamination and disease of certain commercial crops. The Company's primary fluid solution, branded Hydrolyte®, is an EPA registered "hospital-level" disinfectant effective against common healthcare pathogens such as Tuberculosis (TB), HIV-1, Hepatitis C, Norovirus, Rhinovirus, Influenza A, Candida albicans, and more; food processing bacteria including E. coli, Listeria, and Salmonella; and organisms of veterinarian concern such as parvovirus, distemper and Bordetella. PCT Corp.'s proprietary equipment product line includes: 1) PCT Hydrolyte® Generators, 2) PCT Annihilyzer® Infection Control Systems, and 3) SurvivaLyte® equipment. The Hydrolyte® Generators produce large volumes of electrolyzed water for the agriculture, oil and gas, and fluid distribution markets. The Annihilyzer® Infection Control Systems, which boast patented RFID material tracking technology, Electrostatic Smart Applicators, on-site automated ECA generators, and Green Seal standards containing stringent performance, health, and sustainability criteria, are ideal for hospitals and healthcare facilities. The SurvivaLyte® unit is a portable, small volume generator with applications such as disaster recovery, emergency preparedness, remote on-site needs, farm and ranch, and personal use. PCT Corp's unique patented systems and human-safe products provide next-generation cleaning, sanitizing, disinfecting and decontaminating fluid solutions to the ever-present problems of microbial infection and infestation.

This press release contains "forward-looking statements" as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21B of the Securities Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be "forward-looking statements."

Such statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Such statements involve risks and uncertainties, including but not limited to: any implied or perceived benefits resulting from the presentation at APIC; continued positive results relating to the installation of PCT’s Annihilyzer® systems in hospitals; the results of any manufacturers’ representative and/or license agreements, actual sales revenue to be derived from agreements; PCT LTD's and its subsidiary’s business prospects; PCT LTD’s ability to raise sufficient funds to satisfy its working capital requirements; the ability of PCT LTD to execute its business plan or list its common stock on a national stock exchange; benefits of the Annihilyzer® Infection Control Systems, Hydrolyte® generators and fluids; any other effects resulting from the information disclosed above; risks and effects of legal and administrative proceedings and government regulation; future financial and operational results; competition; general economic conditions; and the ability to manage and continue growth. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated.

Important factors that could cause actual results to differ materially from the forward-looking statements PCT LTD makes in this press release include market conditions and those set forth in reports or documents it files from time to time with the United States Securities Exchange Commission. PCT LTD undertakes no obligation to revise or update such statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Gary Grieco, Chairman of the Board

(843) 390-7900 Office

(843) 390-2347 Fax

Brokers and Analysts:

Chesapeake Group

(410)825-3930

info@chesapeakegp.com

Founded in 2013, Uptick Newswire is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market. Uptick provides companies with customized solutions to their news distribution in both national and international media outlets. Uptick is the sole producer of its “Stock Day” Podcast, which is the number one radio show of its kind in America. The Uptick Network “Stock Day” Podcast is an extension of Uptick Newswire, which recently launched its Video Interview Studio located in Phoenix, Arizona.

More news and information about PCT Ltd.

Published By:

Globe Newswire: 14:00 GMT Monday 11th February 2019

Published: .

Search for other references to "uptick" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us